OTCQX
CXXIF

C21 Investments Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

C21 Investments Inc Stock Price

Vitals

Today's Low:
$0.3391
Today's High:
$0.363
Open Price:
$0.355
52W Low:
$0.176
52W High:
$0.4
Prev. Close:
$0.352
Volume:
18176

Company Statistics

Market Cap.:
$33.87 million
Book Value:
0.314
Revenue TTM:
$29.51 million
Operating Margin TTM:
21.4%
Gross Profit TTM:
$18.81 million
Profit Margin:
4.68%
Return on Assets TTM:
6.22%
Return on Equity TTM:
10.01%

Company Profile

C21 Investments Inc had its IPO on under the ticker symbol CXXIF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. C21 Investments Inc has a staff strength of 0 employees.

Stock update

Shares of C21 Investments Inc opened at $0.36 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.34 - $0.36, and closed at $0.36.

This is a +3.13% increase from the previous day's closing price.

A total volume of 18,176 shares were traded at the close of the day’s session.

In the last one week, shares of C21 Investments Inc have increased by +19.41%.

C21 Investments Inc's Key Ratios

C21 Investments Inc has a market cap of $33.87 million, indicating a price to book ratio of 0.7959 and a price to sales ratio of 0.8446.

In the last 12-months C21 Investments Inc’s revenue was $29.51 million with a gross profit of $18.81 million and an EBITDA of $7.58 million. The EBITDA ratio measures C21 Investments Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, C21 Investments Inc’s operating margin was 21.4% while its return on assets stood at 6.22% with a return of equity of 10.01%.

In Q3.3333333333333, C21 Investments Inc’s quarterly earnings growth was a negative -91.6% while revenue growth was a negative 9.2%.

C21 Investments Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
7.026
PEG

Its diluted EPS in the last 12-months stands at $0.04 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into C21 Investments Inc’s profitability.

C21 Investments Inc stock is trading at a EV to sales ratio of 1.3974 and a EV to EBITDA ratio of 3.4763. Its price to sales ratio in the trailing 12-months stood at 0.8446.

C21 Investments Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$61.28 million
Total Liabilities
$14.50 million
Operating Cash Flow
$0
Capital Expenditure
$11095
Dividend Payout Ratio
0%

C21 Investments Inc ended 2024 with $61.28 million in total assets and $0 in total liabilities. Its intangible assets were valued at $61.28 million while shareholder equity stood at $37.67 million.

C21 Investments Inc ended 2024 with $0 in deferred long-term liabilities, $14.50 million in other current liabilities, in common stock, $-66097963.00 in retained earnings and $28.54 million in goodwill. Its cash balance stood at $2.31 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

C21 Investments Inc’s total current assets stands at $10.60 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $252966.00 compared to accounts payable of $1.38 million and inventory worth $5.55 million.

In 2024, C21 Investments Inc's operating cash flow was $0 while its capital expenditure stood at $11095.

Comparatively, C21 Investments Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.36
52-Week High
$0.4
52-Week Low
$0.176
Analyst Target Price
$

C21 Investments Inc stock is currently trading at $0.36 per share. It touched a 52-week high of $0.4 and a 52-week low of $0.4. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.29 and 200-day moving average was $0.26 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1648.2% of the company’s stock are held by insiders while 761.6% are held by institutions.

Frequently Asked Questions About C21 Investments Inc

The stock symbol (also called stock or share ticker) of C21 Investments Inc is CXXIF

The IPO of C21 Investments Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$2.42
-0.03
-1.22%
$40.09
0.03
+0.07%
$478.6
-16.7
-3.37%
$3950
50
+1.28%
$0.07
-0.01
-7.14%
$21.12
0.2
+0.96%
$404.7
-29.75
-6.85%
$1.74
-0.02
-1.14%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.

Address

601 West Cordova, Vancouver, BC, Canada, V6B 1G1